When can tyrosine kinase inhibitors be discontinued in patients with chronic myeloid leukemia?

When can tyrosine kinase inhibitors be discontinued in patients with chronic myeloid leukemia? Clin Adv Hematol Oncol. 2019 Feb;17(2):101-103 Authors: Mahon FX PMID: 30845112 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research